Clinical Trial Update: A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 [Phase 2]

View source ↗

Summary

This report updates the completion of a Phase 2 study evaluating cellular and immunologic changes in the skin of psoriasis patients treated with PH-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• PH-10

Snippet

Sponsor: Provectus Pharmaceuticals | Conditions: Psoriasis | Phase 2 | Status: COMPLETED